Back

Exogenous ketosis fails to mitigate cardiac dysfunction, mitochondrial and inflammatory dysregulation in acute doxorubicin-induced cardiotoxicity

28 August 2026 (13:15 - 13:25)
Organised by: Logo
Congress Presentation Part of: Beyond heart failure in cardio-oncology: immune injury, vascular remodelling, and structural heart disease Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Bertha Polegato

Faculty of Medicine of Botucatu, UNESP, Botucatu (Brazil)

5 More presentations in this session

Presentation thumbnail
Procedural success after M-TEER in cancer patients: a single-center study
Doctor J. Soldat (Essen, DE)
Abstract Slides Video
Presentation thumbnail
FOXA1+CD3+T lymphocytes exacerbate myocardial injury in immune checkpoint inhibitor associated myocarditis via the DLL1/Notch1/GSDMD signaling pathway
Associate Professor X. Liu (Jinan, CN)
Abstract Slides Video
Presentation thumbnail
Longitudinal [¹⁸F]FDG PET/MR assessment of arterial inflammation in prostate cancer patients undergoing androgen deprivation therapy
Doctor C. Hu (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of transcatheter mitral edge-to-edge repair in cancer survivors according to MR etiology
Mr L. Barreiro Mesa (Cordoba, ES)
Abstract Slides Video
Presentation thumbnail
Elevated circulating DKK1 is associated with pulmonary vascular remodeling in early-stage non-small cell lung cancer
Associate Professor M. Li (Jinan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Beyond heart failure in cardio-oncology: immune injury, vascular remodelling, and structural heart disease
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Session
Translational frontiers in cardio-oncology
19 June 2026
thumbnail
Congress Presentation
Chalcone-enriched fraction protects against chemotherapy-induced cardiotoxicity by restoring mitochondrial function and reducing oxidative stress
31 August 2025
thumbnail
Congress Presentation
Repeated low doses of doxorubicin induce senescence and functional decline in dyn-EHTs which can be rescued using senomorphics.
22 May 2022
thumbnail
Congress Presentation
Targeting mitochondrial dysfunction with the exercise-derived metabolite beta-aminoisobutyric acid protects against doxorubicin-induced cardiomyopathy
23 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources